Headline RoundupDecember 11th, 2020

FDA Panel Endorses Authorization of Pfizer-BioNTech Vaccine for Emergency Use

Summary from the AllSides News Team

A Food and Drug Administration (FDA) committee voted 17-4, with one abstention, on Thursday to recommend the Pfizer-BioNTech COVID-19 coronavirus vaccine for emergency use. The committee's votes considered whether benefits of the vaccine outweigh the potential risks for people aged 16 and older. Final FDA approval could happen as soon as Friday, and healthcare workers and nursing home patients would begin receiving the first vaccine doses shortly after that. Health officials expect that the vaccine won't available to the general public until Spring 2021. Coverage was similar on all sides of the spectrum. Many reports from left- and center-rated sources also previewed how the vaccine distribution process may go and what complications may arise.

Featured Coverage of this Story

More headline roundups

AllSides Picks

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right